Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

Paper-Based and Smartphone-Based Memory Supports

NCT06444841

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +20 more
Locations: UT Health Austin Comprehensive Memory Center Austin, Texas, United States

Baylor Scott & White Healthcare Temple, Texas, United States

Baylor University Waco, Texas, United States

View Trial Details

Recruiting

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

NCT05636787

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Departement of Medical Oncology, University Hospital Berne Bern, Switzerland

View Trial Details

Recruiting

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

NCT06430736

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Insel Gruppe AG Bern, Canton of Bern, Switzerland

View Trial Details

Recruiting

A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment

NCT06109233

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: The First Hospital of Jilin University Changchun, Jilin, China

View Trial Details

Recruiting

CAR-T-cell Treatment for Untreated High Risk MANtle Cell Lymphoma

NCT06482684

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: University Hospital of Mainz Mainz, Germany

Klinikum der Universität München Munich, Germany

View Trial Details

Recruiting

Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)

NCT05029531

Conditions: ALL, Infants, Acute Lymphoblastic Leukemia, Pediatric, Hematologic Diseases, +10 more
Locations: Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, Samory-Mashela,1, Russia

View Trial Details

Recruiting

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

NCT06477549

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Biphenotypic Acute Leukemia, +19 more
Locations: RM Gorbacheva Research Institute Saint Petersburg, Russia

View Trial Details

Recruiting

Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious Risk

NCT06475469

Conditions: Bronchial Diseases, Bronchiectasis, Chronic Disease, +18 more
Locations: Chu Reims Reims, France

View Trial Details

Recruiting

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

NCT06463717

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: The First Affiliated Hospital of Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Recruiting

Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.

NCT06454968

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions